SARS-CoV-2 Rapid Antigen Test Nasal |
|
9901-NCOV-03G |
Roche Diagnostics |
25 Tests/Kit |
EUR 112.8 |
|
|
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
Human IgG antibody Laboratories manufactures the is sars antigen test sofia 2 test reagents distributed by Genprice. The Is Sars Antigen Test Sofia 2 Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Is products are available in stock. Specificity: Is Category: Sars Group: Antigen Test
Chikungunya IgG/IgM Test Card |
|
Innovation Biotech |
4.0mm (strip in a card) 25cards/box |
EUR 0.7 |
CA50 (Cancer antigen) ELISA test |
|
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of CA50 (Cancer antigen) |
CA199 (Cancer antigen) ELISA test |
|
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of CA199 (Cancer antigen) |
CA153 (Cancer antigen) ELISA test |
|
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of CA153 (Cancer antigen) |
CA125 (Cancer antigen) ELISA test |
|
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of CA125 (Cancer antigen) |
CEA (Cancer antigen) ELISA test |
|
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of CEA (Cancer antigen) |
Antigen Test information
CA199 (Cancer antigen) ELISA test |
|
13 |
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of CA199 (Cancer antigen) |
CA153 (Cancer antigen) ELISA test |
|
12 |
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of CA153 (Cancer antigen) |
CA125 (Cancer antigen) ELISA test |
|
11 |
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of CA125 (Cancer antigen) |
GA COVID-19 Rapid Antigen Test |
|
BSV-3980 |
BioServUK |
20 tests |
Ask for price |
|
Description: GA COVID-19 Rapid Antigen Test |
PSA (Prostate-specific antigen) ELISA test |
|
8 |
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of PSA (Prostate-specific antigen) |
